Bullish
IDEXX Laboratories, Inc. has expanded its Fecal Dx™ antigen testing platform to include taeniid tapeworm detection (Taenia and Echinococcus species), ...
Bullish
Elyxium Wealth LLC has made a significant new investment in IDEXX Laboratories, acquiring approximately 5.4 million shares valued at $3.67 billion, wh...
Bullish
IDEXX Laboratories reported strong Q1 2026 results, surpassing EPS estimates by $0.06 with earnings of $3.47 and exceeding revenue expectations with a...
Bullish
The average 12-month price target for IDEXX Laboratories, Inc. (IDXX) stock has been trimmed slightly to $714.36 from $721.5 by 11 analysts. This new ...